News & Updates

Adding lenzilumab, a monoclonal antibody targeting GM-CSF, on top of standard supportive care significantly improves survival without the need of invasive mechanical ventilation at 28 days in patients hospitalized with COVID-19 compared with standard care alone, reveals the LIVE-AIR study.

The combination of mesalamine plus corticosteroid does not appear to be more beneficial than corticosteroid alone in the treatment of hospitalized patients with acute severe ulcerative colitis (UC), as shown in a study.

Handling of chemotherapy drugs remains unsafe in many low- (LICs) and middle-income countries (LMICs), reveals a study.

Elevations in intraocular pressure (IOP) occur commonly in uveitis patients who are receiving treatment with topical difluprednate, a study has found. This IOP elevation risk is pronounced among children and adult patients with concurrent systemic corticosteroids.

New drug applications approved by US FDA as of 16-31 March 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.